Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Clinical Significance of MPL Mutations in Essential Thrombocythemia: Analysis of the PT-1 Cohort.

Philip Beer, Peter Campbell, Wendy Erber, Linda Scott, Anthony Bench, David Bareford, Wilkins Bridget, Keith Wheatley, Georgina Buck, Claire Harrison, Anthony Green

Blood (2007) 110 (11): 677.

https://doi.org/10.1182/blood.V110.11.677.677

Published: 2007

Journal Articles

JAK2 V617F Mutation Identifies a Biologically Distinct Subtype of Essential Thrombocythemia Which Resembles Polycythemia Vera.

Anthony Green, Peter Campbell, Linda Scott, Georgina Buck, Keith Wheatley, Clare East, Joanne Marsden, Audrey Duffy, Elaine Boyd, Anthony Bench, Mike Scott, George Vassiliou, Don Milligan, Steve Smith, Wendy Erber, David Bareford, Bridget Wilkins, John Reilly, Claire Harrison

Blood (2005) 106 (11): 253.

https://doi.org/10.1182/blood.V106.11.253.253

Published: 2005

Journal Articles

A Role for SCL in Developing Bone? the SCL +19 Core Enhancer Targets Expression to Cells of Developing Bone, Osteocytes, Chondrocytes and Bone Lining Cells.

Lev Silberstein, MD, John E. Pimanda, MD, PhD, Sandie Piltz, Liz Delaney, Scott Oldham, Asha Kallianpur, MD, Massimo Dominici, MD, Stephen Brandt, MD, Berthold Gottgens, PhD, Anthony Green, MD, PhD

Blood (2004) 104 (11): 4199.

https://doi.org/10.1182/blood.V104.11.4199.4199

Published: 2004

Journal Articles

The Medical Research Council PT1 Trial in Essential Thrombocythemia.

Anthony Green, Peter Campbell, Georgina Buck, Keith Wheatley, Clare East, David Bareford, Bridget Wilkins, Jon Van der Walt, John Reilly, Claire Harrison

Blood (2004) 104 (11): 6.

https://doi.org/10.1182/blood.V104.11.6.6

Published: 2004

Journal Articles

Genome-Wide Identification of Cis-Regulatory Sequences Controlling Blood and Endothelial Development.

Berthold Göttgens, Ian J. Donaldson, Michael Chapman, Sarah Kinston, Josette Renée Landry, Kathy Knezevic, Sandie Piltz, Noel Buckley, Anthony Green

Blood (2004) 104 (11): 1616.

https://doi.org/10.1182/blood.V104.11.1616.1616

Published: 2004

NARROW

Clinical Significance of MPL Mutations in Essential Thrombocythemia: Analysis of the PT-1 Cohort.

JAK2 V617F Mutation Identifies a Biologically Distinct Subtype of Essential Thrombocythemia Which Resembles Polycythemia Vera.

A Role for SCL in Developing Bone? the SCL +19 Core Enhancer Targets Expression to Cells of Developing Bone, Osteocytes, Chondrocytes and Bone Lining Cells.

The Medical Research Council PT1 Trial in Essential Thrombocythemia.

Genome-Wide Identification of Cis-Regulatory Sequences Controlling Blood and Endothelial Development.

Email alerts

ASH Publications

American Society of Hematology

Clinical Significance of MPL Mutations in Essential Thrombocythemia: Analysis of the PT-1 Cohort.

JAK2 V617F Mutation Identifies a Biologically Distinct Subtype of Essential Thrombocythemia Which Resembles Polycythemia Vera.

A Role for SCL in Developing Bone? the SCL +19 Core Enhancer Targets Expression to Cells of Developing Bone, Osteocytes, Chondrocytes and Bone Lining Cells.

The Medical Research Council PT1 Trial in Essential Thrombocythemia.

Genome-Wide Identification of Cis-Regulatory Sequences Controlling Blood and Endothelial Development.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only